Which medications in the drug class Antidiabetics, Thiazolidinediones are used in the treatment of Metabolic Syndrome?

Updated: Oct 17, 2019
  • Author: Stanley S Wang, JD, MD, MPH; Chief Editor: Yasmine S Ali, MD, FACC, FACP, MSCI  more...
  • Print
Answer

Antidiabetics, Thiazolidinediones

Thiazolidinediones may produce favorable metabolic alterations as single agents in patients with metabolic syndrome. These agents are highly selective agonists for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Activation of PPAR-gamma receptors regulate insulin-responsive gene transcription involved in glucose production, transport, and use, thereby reducing blood glucose concentrations and reducing hyperinsulinemia.

Rosiglitazone (Avandia)

Rosiglitazone is available only via a restricted access program. It is an insulin sensitizer with a major effect in the stimulation of glucose uptake in skeletal muscle and adipose tissue. It lowers plasma insulin levels and is used to treat type 2 diabetes associated with insulin resistance.

Pioglitazone (Actos)

Pioglitazone improves target cell response to insulin without increasing insulin secretion from the pancreas. It decreases hepatic glucose output and increases insulin-dependent glucose use in skeletal muscle and, possibly, in liver and adipose tissue.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!